During today's session, Dr Reddys Laboratories experienced a notable surge, climbing 2.90% to reach Rs 1,142.60. This increase was accompanied by a significant rise in trading volume, suggesting ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 advanced 4.21% to 1,155.80 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and ...

JSW MG Motor will kickstart a new chapter when it brings out the first set of Completely Built Units (CBU) to India. Last year, the Chinese-owned British carmaker announced that it will launch ...

The strength also will be expressed in terms of the active moiety (e.g., ‘100 mg newdrug ... metoprolol tartrate (Lopressor) is an immediate-release beta blocker that is dosed twice daily; metoprolol ...

February 25, 2025 Indian drugmakers likely to stay competitive as US tariffs loom, Dr Reddy's says Indian drugmakers are likely to remain competitive in the generics market even as U.S. President ...

Shares of major Indian pharmaceutical companies on Wednesday, including Aurobindo Pharma, Sun Pharmaceutical Industries (Sun Pharma), Zydus Lifesciences, Dr. Reddy's Laboratories, Gland Pharma and ...

Over a month after Ranveer Allahbadia's ‘obscene’ remarks on Samay Raina's India's Got Latent show spiralled into a huge controversy, and the Supreme Court finally granted him bail after his ...

Empuraan finally entered the Rs 100 crore club in India, on the 12th day of its release. As per industry tracker Sacnilk, Empuraan earned Rs 1.25 crore (early estimates) on Day 13, taking the ...